AeroLeads people directory · profile
Per Grufman Email & Phone Number
Chief Executive Officer
at
Biocrucible
LinkedIn matched
3 data sources
Profile completeness 86%
Current company
Role
Chief Executive Officer
Location
Saffron Walden, England, United Kingdom
Who is Per Grufman? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Per Grufman is listed as Chief Executive Officer at Biocrucible, based in Saffron Walden, England, United Kingdom. AeroLeads shows a matched LinkedIn profile for Per Grufman.
Per Grufman previously worked as Consultant and Advisor to Biotech companies at Self-Employed and CxO at Leopard Biosciences. Per Grufman holds Phd, Immunology from Karolinska Institutet.
Company email context
Email format at Biocrucible
This section adds company-level context without repeating Per Grufman's masked contact details.
Biocrucible
Review company-level records connected to Per Grufman before choosing the right outreach path.
Profile bio
About Per Grufman
CEO and VP of Research and Development with a demonstrated history of working in the medical device industry. Experience from most aspects of medical devices and diagnostics. Skilled in Medical Devices, Diagnostics, , Molecular Biology, Biotechnology, Research and Development and crossfunctional leadership. Strong research professional with a PhD focused in Immunology from Karolinska institutet.Lives in Cambridge, UK and also have an apartment in Stockholm, Sweden.Any views or comments that I express are my own and does not reflect the views of my employer
Current workplace
Per Grufman's current company
Company context helps verify the profile and gives searchers a useful next step.
10 roles
Per Grufman work experience
A career timeline built from the work history available for this profile.
Consultant And Advisor To Biotech Companies
Current
Self-Employed
Consultant and Advisor working with biotech companies in Europe. Currently supporting a German molecular diagnostic company as well as a French medical device company. Providing expertise in product development, investor relations, business development etc.
Dec 2024 - Present
Cxo
CurrentLeopard Biosciences develops molecular diagnostics aiming primarily on the point of care market. The company has developed a unique technology based on CRISPR.
Dec 2024 - Present
Chief Executive Officer
Biocrucible is a part of the Sapphiros group and are developing molecular and lateral flow diagnostics. The company has almost 80 staff that are based across two locations in Cambridge. For molecular diagnostics we utilise the unique molten RPA technology that allows us to develop and manufacture very low cost instrument free molecular diagnostics.
Jan 2023 - Dec 2024
Vp Of R&D
Responsibility includes responsibility for POC V&V, Product Life cycle management including investigations as well as product development for molecular assays on the LumiraDx point of care platform.
Jun 2021 - Dec 2022
Executive Director Research And Development, Sweden
Cepheid is providing molecular diagnostics assays in all parts of the world. The main strengths of the platform is the ease of use and ability to operate in all types of environments. The R&D team in Sweden consist of 50+ associates focused on developing assays for the GeneXpert platform. The team has developed multiple assays for infectious diseases.
Apr 2015 - May 2021
Senior Director Research And Development, Sweden
Cepheid is developing and marketing molecular diagnostic products based on real time PCR. Responsibilities include Research strategy and guidance of staff.
Jun 2010 - Apr 2015
Vp, Head Of Research And Development
AbSorber is developing and selling products for the organ transplantation market.Responsibility included Research strategy and guidance of scientific staff, research collaborations, intellectual property issues, Clinical studies, Regulatory affairs etc. I was responsible for the development of the first product the company developed which was used to.
Jul 2004 - Jun 2010
Vp Murine Research
Accuro Immunology Ab
Accuro Immunology AB was developing therapeutic cancer vaccines. The first product which was a cell based vaccine was ready to go into safety and toxicity studies. Responsibilities included animal models (mice) and molecular biology, guidance and training of scientific staff working within these areas, work with intellectual property issues, research.
May 2003 - Jun 2004
Team Leader Murine Research
Accuro Immunology Ab
Jun 2000 - Apr 2003
2 education records
Per Grufman education
Phd, Immunology
Karolinska Institutet
Master Of Science (Fil Mag), Biology
Stockholm University
FAQ
Frequently asked questions about Per Grufman
Quick answers generated from the profile data available on this page.
What company does Per Grufman work for?
Per Grufman works for Biocrucible.
What is Per Grufman's role at Biocrucible?
Per Grufman is listed as Chief Executive Officer at Biocrucible.
Where is Per Grufman based?
Per Grufman is based in Saffron Walden, England, United Kingdom while working with Biocrucible.
What companies has Per Grufman worked for?
Per Grufman has worked for Biocrucible, Self-Employed, Leopard Biosciences, Lumiradx, and Cepheid Ab.
How can I contact Per Grufman?
You can use AeroLeads to view verified contact signals for Per Grufman at Biocrucible, including work email, phone, and LinkedIn data when available.
What schools did Per Grufman attend?
Per Grufman holds Phd, Immunology from Karolinska Institutet.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial